Yurie Yamada

Posted by on Aug 5, 2021 in |

Yurie received Ph.D. from Niigata University in Japan. She obtained D.D.S and board certified dentist of Japanese dental society of anesthesiology. She was interested in mechanism of axonal degeneration and regeneration through clinical experience of treatment for patients who got nerve injury, and joined Milbrandt lab to study it. Her research focuses on the cellular mechanism of neurodegenerative disease and mitochondrial function in neuron...

Read More

Waleed Minzel

Posted by on Apr 19, 2021 in |

Waleed received his Ph.D. from the Hebrew University in Jerusalem, Israel, where he studied the intracellular signaling mechanisms underlying abnormal proliferation in the setting of blood cancer transformation. Waleed becomes interested in the basic questions regarding the role of mitochondria biology and its contribution to neuronal death and axon degeneration and he joined Milbrandt’s lab. Combining functional genomics approach using...

Read More

Tong Wu

Posted by on Apr 15, 2021 in |

Tong was interested in applying engineering ways to improve human health. He started his B.S. study in health science with minor study in electrical engineering from Peking University. Then he finished his study of BME M.Phil. program from HKUST. In this lab, he is interested in figuring out the signal pathways of axon degeneration and neuron death in axotomy model and other neurodegenerative models, respectively. He cherishes the chance of...

Read More

Alicia Neiner

Posted by on Jul 23, 2020 in |

Alicia Neiner received a Bachelor of Science in Sustainability Science and Environment from Washington University. She’s an analytical chemist who’s worked with liquid chromatography-tandem mass spectrometry and high-performance liquid chromatography instruments for the last 10 years. She runs samples for many researchers in the Milbrandt and Di’Antonio labs. She previously worked in the Anesthesiology Department where she developed and...

Read More

Fengping Dong

Posted by on Jul 20, 2020 in |

Fengping received his PhD from the Pennsylvania State University where he studied risk genes related to schizophrenia and autism spectrum disorders. Fengping joined the Milbrandt and Mitra labs with interests of applying a series of functional genomics tools to understand neurodevelopmental diseases. Combining CRISPR/Cas9-mediated gene regulation with next-generation sequencing, he aims to discover underlying molecular mechanisms of...

Read More